Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biotech Blunder Turned 20% Overnight Gain
Biotech Blunder Turned 20% Overnight Gain
Biotech Blunder Turned 20% Overnight Gain
Submitted by
admin
on October 25, 2011 - 9:25am
Source:
Motley Fool
News Tags:
Exelixis
medullary thyroid cancer
cabozantinib
Headline:
Biotech Blunder Turned 20% Overnight Gain
Do Not Allow Advertisers to Use My Personal information
